Wall Street brokerages predict that Zynex, Inc. (NASDAQ:ZYXI – Get Rating) will report $36.42 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for Zynex’s earnings, with the highest sales estimate coming in at $36.76 million and the lowest estimate coming in at $36.00 million. Zynex […]
Zynex (NASDAQ:ZYXI – Get Rating) and Natus Medical (NASDAQ:NTUS – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Insider & Institutional Ownership 28.1% of Zynex shares are held […]
Zynex (NASDAQ:ZYXI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Saturday, Zacks.com reports. According to Zacks, “Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Analysts forecast that Zynex, Inc. (NASDAQ:ZYXI – Get Rating) will post earnings of $0.05 per share for the current quarter, according to Zacks. Three analysts have made estimates for Zynex’s earnings, with estimates ranging from $0.04 to $0.06. Zynex posted earnings per share of ($0.02) during the same quarter last year, which would indicate a […]